These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1347798)
1. Differential effects of LHRH and somatostatin analogs on human breast cancer. Brower ST; Schally AV; Redding TW; Hollander VP J Surg Res; 1992 Jan; 52(1):6-14. PubMed ID: 1347798 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160. Milovanovic SR; Radulovic S; Groot K; Schally AV Prostate; 1992; 20(4):269-80. PubMed ID: 1376910 [TBL] [Abstract][Full Text] [Related]
3. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Schally AV; Redding TW Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164 [TBL] [Abstract][Full Text] [Related]
4. Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma. Srkalovic G; Szende B; Redding TW; Groot K; Schally AV Proc Soc Exp Biol Med; 1989 Dec; 192(3):209-18. PubMed ID: 2574866 [TBL] [Abstract][Full Text] [Related]
5. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Emons G; Ortmann O; Becker M; Irmer G; Springer B; Laun R; Hölzel F; Schulz KD; Schally AV Cancer Res; 1993 Nov; 53(22):5439-46. PubMed ID: 8221683 [TBL] [Abstract][Full Text] [Related]
6. Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin. Lee LT; Schally AV; Liebow C; Lee PP; Lee PH; Lee MT Anticancer Res; 2008; 28(5A):2599-605. PubMed ID: 19035284 [TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP. Limonta P; Dondi D; Moretti RM; Maggi R; Motta M J Clin Endocrinol Metab; 1992 Jul; 75(1):207-12. PubMed ID: 1320049 [TBL] [Abstract][Full Text] [Related]
8. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells. Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718 [TBL] [Abstract][Full Text] [Related]
9. Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer. Fekete M; Zalatnai A; Schally AV Cancer Lett; 1989 May; 45(2):87-91. PubMed ID: 2567204 [TBL] [Abstract][Full Text] [Related]
10. Membrane receptors for peptides in experimental and human pancreatic cancers. Fekete M; Zalatnai A; Comaru-Schally AM; Schally AV Pancreas; 1989; 4(5):521-8. PubMed ID: 2573055 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Yano T; Pinski J; Radulovic S; Schally AV Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1701-5. PubMed ID: 8127868 [TBL] [Abstract][Full Text] [Related]
12. Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin. Kadar T; Redding TW; Ben-David M; Schally AV Proc Natl Acad Sci U S A; 1988 Feb; 85(3):890-4. PubMed ID: 2893378 [TBL] [Abstract][Full Text] [Related]
13. Effect of treatment with LHRH analogs containing cytotoxic radicals on the binding characteristics of receptors for luteinizing-hormone-releasing hormone in MXT mouse mammary carcinoma. Milovanovic SR; Monje E; Szepeshazi K; Radulovic S; Schally A J Cancer Res Clin Oncol; 1993; 119(5):273-8. PubMed ID: 8382705 [TBL] [Abstract][Full Text] [Related]
14. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor. Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331 [TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination. Szepeshazi K; Milovanovic S; Lapis K; Groot K; Schally AV Breast Cancer Res Treat; 1992; 21(3):181-92. PubMed ID: 1355375 [TBL] [Abstract][Full Text] [Related]
16. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Lee MT; Liebow C; Kamer AR; Schally AV Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1656-60. PubMed ID: 1672042 [TBL] [Abstract][Full Text] [Related]
17. Novel antitumor peptide hormones and their effect on signal transduction. Kéri G; Balogh A; Horváth A; Mezö I; Vadász Z; Bökönyi G; Bajor T; Vántus T; Teplán I; Horváth J J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):105-10. PubMed ID: 1356011 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer. Fekete M; Wittliff JL; Schally AV J Clin Lab Anal; 1989; 3(3):137-47. PubMed ID: 2569034 [TBL] [Abstract][Full Text] [Related]
19. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. Szende B; Zalatnai A; Schally AV Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1643-7. PubMed ID: 2564204 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of binding of cytotoxic analogs of luteinizing hormone-releasing hormone to human breast cancer and mouse MXT mammary tumor. Milovanovic SR; Radulovic S; Schally AV Breast Cancer Res Treat; 1992; 24(2):147-58. PubMed ID: 8443402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]